BBIO - BridgeBio Pharma GAAP EPS of -$0.92 revenue of $1.83M May, 04 2023 10:08 AM BridgeBio Pharma Inc. 2023-05-04 10:08:25 ET BridgeBio Pharma press release ( NASDAQ: BBIO ): Q1 GAAP EPS of -$0.92. Revenue of $1.83M (+8.3% Y/Y). For further details see: BridgeBio Pharma GAAP EPS of -$0.92, revenue of $1.83M